Discovery of two novel (4-hydroxyphenyl) substituted polycyclic carbocycles as potent and selective estrogen receptor beta agonists

被引：0

作者：

Wetzel, Edward A. ^{[1
]}

Marks, Kylee J. ^{[2
]}

Gleason, Alexandra A. ^{[2
]}

Brown-Ford, Sandra ^{[2
]}

Reid, Terry-Elinor ^{[2
]}

Chaudhury, Subhabrata ^{[1
]}

Lindeman, Sergey ^{[1
]}

Sem, Daniel S. ^{[2
]}

Donaldson, William A. ^{[1
]}

机构：

[1] Marquette Univ, Dept Chem, PO Box 1881, Milwaukee, WI 53201 USA

[2] Concordia Univ Wisconsin, Ctr Struct based Drug Design & Dev, Sch Pharm, Mequon, WI 53097 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2022年 / 73卷

关键词：

SERBA; Estrogen receptor agonist; Drug development; Docking; CARBORANE; ALPHA;

D O I：

10.1016/j.bmcl.2022.128906

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Two (4-hydroxyphenyl) substituted polycyclic carbocycles were prepared and assayed for estrogen receptor activity. 4-(4-Hydroxyphenyl)tricyclo[3.3.1.1(3,7)]decane-1-methanol (5a/b) and 7-(4-hydroxyphenyl)spiro[3.5] nonan-2-ol ((+/-)-11) were found to be potent ER beta agonists (1.9 +/- 0.4 nM and 6.2 +/- 1.4 nM respectively) in a cell -based functional assay. Furthermore, both 5a/b and 11 were highly selective for ER beta over ER alpha (377 and 1,100 -fold selective respectively). While neither compound inhibited CYP2D6 or CYP3A4 at concentrations up to 62.5 mu M, 5a/b did have weak binding to CYP2C9 with an IC50 of 10 +/- 0.5 mu M. Computational assessment of 5a/b and 11 predicted the most probable site of metabolism would be ortho to the phenolic hydroxyl group.

引用

页数：5

共 50 条

[21] Synthesis of N-substituted 4-(4-hydroxyphenyl)piperidines, 4-(4-hydroxybenzyl)piperidines, and (±)-3-(4-hydroxyphenyl)pyrrolidines:: Selective antagonists at the 1A/2B NMDA receptor subtype
Guzikowski, AP
Tamiz, AP
Acosta-Burruel, M
Hong-Bae, S
Cai, SX
Hawkinson, JE
Keana, JFW
Kesten, SR
Shipp, CT
Tran, M
Whittemore, ER
Woodward, RM
Wright, JL
Zhou, ZL
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (05) : 984 - 994
[22] Discovery, design and synthesis of novel potent and selective sphingosine-1-phosphate 4 receptor (S1P4-R) agonists
Guerrero, Miguel
Urbano, Mariangela
Zhao, Jian
Crisp, Melissa
Chase, Peter
Hodder, Peter
Schaeffer, Marie-Therese
Brown, Steven
Rosen, Hugh
Roberts, Edward
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (01) : 537 - 542
[23] Novel Bisaryl Substituted Thiazoles and Oxazoles as Highly Potent and Selective Peroxisome Proliferator-Activated Receptor δ Agonists
Epple, Robert
Cow, Christopher
Xie, Yongping
Azimioara, Mihai
Russo, Ross
Wang, Xing
Wityak, John
Karanewsky, Donald S.
Tuntland, Tove
Nguyen-Tran, Van T. B.
Ngo, Cara Cuc
Huang, David
Saez, Enrique
Spalding, Tracy
Gerken, Andrea
Iskandar, Maya
Seidel, H. Martin
Tian, Shin-Shay
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (01) : 77 - 105
[24] Discovery of Selective M4 Muscarinic Acetylcholine Receptor Agonists with Novel Carbamate Isosteres
Yang, Qingyi
Lachapelle, Erik A.
Kablaoui, Natasha M.
Webb, Damien
Popiolek, Michael
Grimwood, Sarah
Kozak, Rouba
O'Connor, Rebecca E.
Lazzaro, John T.
Butler, Christopher R.
Zhang, Lei
[J]. ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (06): : 941 - 948
[25] Discovery of fused azetidines as novel selective α4β2 neuronal nicotinic receptor (NNR) agonists
Ji, JG
Bunnelle, WH
Li, T
Pace, JM
Schrimpf, MR
Sippy, KB
Anderson, DJ
Meyer, MD
[J]. PURE AND APPLIED CHEMISTRY, 2005, 77 (12) : 2041 - 2045
[26] A-C Estrogens as Potent and Selective Estrogen Receptor-Beta Agonists (SERBAs) to Enhance Memory Consolidation under Low-Estrogen Conditions
Hanson, Alicia M.
Perera, K. L. Iresha Sampathi
Kim, Jaekyoon
Pandey, Rajesh K.
Sweeney, Noreena
Lu, Xingyun
Imhoff, Andrea
Mackinnon, Alexander Craig
Wargolet, Adam J.
Van Hart, Rochelle M.
Frick, Karyn M.
Donaldson, William A.
Sem, Daniel S.
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (11) : 4720 - 4738
[27] Discovery of the first N-substituted 4β-methyl-5-(3-hydroxyphenyl) morphan to possess highly potent and selective opioid δ receptor antagonist activity
Carroll, FI
Zhang, L
Mascarella, SW
Navarro, HA
Rothman, RB
Cantrell, BE
Zimmerman, DM
Thomas, JB
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (02) : 281 - 284
[28] Discovery of novel prostaglandin analogs as potent and selective EP2/EP4 dual agonists
Kambe, Tohru
Maruyama, Toru
Nakai, Yoshihiko
Yoshida, Hideyuki
Oida, Hiroji
Maruyama, Takayuki
Abe, Nobutaka
Nishiura, Akio
Nakai, Hisao
Toda, Masaaki
[J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (07) : 2235 - 2251
[29] Discovery of a novel class of substituted pyrrolooctahydroisoquinolines as potent and selective delta opioid agonists, based on an extension of the message-address concept
Dondio, G
Ronzoni, S
Eggleston, DS
Artico, M
Petrillo, P
Petrone, G
Visentin, L
Farina, C
Vecchietti, V
Clarke, GD
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (20) : 3192 - 3198
[30] Novel substituted 4-aminomethylpiperidines as potent and selective human β3-agonists.: Part 2:: Arylethanolaminomethylpiperidines
Steffan, RJ
Ashwell, MA
Solvibile, WR
Matelan, E
Largis, E
Han, S
Tillet, J
Mulvey, R
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (20) : 2963 - 2967

← 1 2 3 4 5 →